The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: The UCLA experience 1988-1992

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 1, 1996, Pages 65-72

  Schneider, Scott B ^a   Schweitzer, Victor G ^a   Parker, Robert G ^a   Bycott, Paul W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Prostate cancer; Prostate specific antigen; Radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030026770     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199602000-00014     Document Type: Article

References (7)

1. Stamey TA, Kabalin JN, McNeal JE, et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate in radical prostatectomy treated patients. J Urol 1989;141:1076-83.
2. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter trial of 6,630 men. J Urol 1994;151:1283-90.
3. Pisansky TM, Cha SS, Earle JD, et al. Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer. J Clin Oncol 1993;11:2158-66.
4. Ritter MA, Messing EM, Shanahan TG, et al. Prostate specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J Clin Oncol 1992;10:1208-17.
5. Russell KJ, Dunatov C, Hafermann MD, et al. Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy. J Urol 1991;146:1046-52.
6. Zagars GK, von Eschenbach AC. Prostate specific antigen. Cancer 1993;72:538-48.
7. Zietman AL, Coen JJ, Shipley WU, et al. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. J Urol 1994;151:640-5.